A molecule for every malady 

Anagenex has built a closed-loop directed evolution platform to discover first-in-class and best-in-class novel small molecule medicines. The Anagenex platform interprets the results of iteratively run, massively parallel biochemical experiments using proprietary machine learning (ML) algorithms. Each experimental iteration updates the models with real data and enables the ML system to design the next “evolved” generation of compounds to test. This virtuous cycle of real data perfecting ML models allows us to discover compounds addressing historically intractable medical problems.